Search results
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for...
Morningstar· 1 week agoPfizer Inc. (NYSE: PFE)announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with ...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 5 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 7 days agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible disease may now be “contagious, ...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 3 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
Optimized Hospital Care Improves Gout Treatment Uptake
Medscape· 7 days agoOptimizing how people experiencing a gout flare are managed in hospital and then followed-up afterwards can substantially increase the uptake of guideline-recommended urate-lowering therapy ...